2022 CDC Clinical Practice Guideline for Prescribing Opioids Implementation Guide
2022.1.0 - CI Build

2022 CDC Clinical Practice Guideline for Prescribing Opioids Implementation Guide, published by Centers for Disease Control and Prevention (CDC). This guide is not an authorized publication; it is the continuous build for version 2022.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cqframework/opioid-cds-r4/ and changes regularly. See the Directory of published versions

Resource Profile: CDC_ValueSet - Examples

Draft as of 2018-11-20

Examples for the cdc-valueset Profile.

Amphetamine-class drugs and metabolite urine tests
Amphetamine class medications
Benzodiazepine medications
Buprenorphine and Methadone medications
Cannabinoid class urine drug screening
CDC malignant cancer conditions
CNS depressant medications
Cocaine urine drug screening tests
Condition Clinical Status Active
Encounter Diagnosis Condition Category
Problem List Condition Category
US Core Health Concern Condition Category
Sleep disordered breathing
Conditions documenting substance misuse
Conditions likely terminal for opioid prescribing
Extended release opioid with ambulatory misuse potential
Fentanyl-type medications
Fentanyl-type urine drug screening tests
General opiate urine drug screening tests
Hospice Disposition
Hospice Finding
Hospice Procedure
Limited life expectancy conditions
Methadone urine drug screening tests
Methadone medications
Naloxone medications
Non-opioid drug urine screening
Non-synthetic opioid medications
Observation Category Laboratory
Observation Category Procedure
Office Visit
Oncology specialty designations (NUCC)
Opiate specific urine drug screening tests
Opioid counseling procedure
Opioid drug urine screening
Opioid misuse assessment procedure
Opioid misuse disorders
Opioid treatment assessment procedure
Pain management procedure
Pain treatment plan
PDMP data reviewed finding
PDMP review procedure
Phencyclidine urine drug screening tests
Sickle-cell diseases
Substance misuse behavioral counseling
Synthetic opioid medications
Synthetic opioid urine drug screening tests
Therapies indicating end of life care
Xylazine drug urine screening tests